Zobrazeno 1 - 10
of 55
pro vyhledávání: '"European Association for the Study of Diabetes"'
Autor:
F. Cosentino, P. J. Grant, V. Aboyans, G. J. Bailey, А. Ceriello, V. Delgado, M. Federici, G. Filippatos, D. E. Grobbee, T. В. Hansen, H. V. Huikuri, I. Johansson, P. Jüni, M. Lettino, N. Marx, L. G. Mellbin, C. J. Östgren, B. Rocca, M. Roffi, N. Sattar, P. M. Seferović, M. Sousa-Uva, P. Valensi, D. C. Wheeler
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 4 (2020)
The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Externí odkaz:
https://doaj.org/article/1ab0bd740d014f2bbbc33dba402c0180
Publikováno v:
European Medical Journal Diabetes, Vol 3, Iss 1, Pp 31-38 (2015)
This symposium aimed to address the current issues in the management of patients with Type 2 diabetes (T2D) post-acute coronary syndrome (ACS), bringing together the views of both cardiologists and diabetologists. T2D increases the risk of ACS and is
Externí odkaz:
https://doaj.org/article/8852e306c13a4f27a1ca7617de4fd4f2
Publikováno v:
European Medical Journal Diabetes, Vol 2, Iss 1, Pp 35-41 (2014)
This Takeda-sponsored European Association for the Study of Diabetes (EASD) symposium addressed the pharmacology, clinical use, and future therapeutic application of dipeptidyl-peptidase-4 (DPP-4) inhibitors. The scientific programme covered the clin
Externí odkaz:
https://doaj.org/article/57842095e1644ca1b7074b680df5e24e
Autor:
Michael Nauck, Dídac Mauricio, Anthony Barnett, Tina Vilsbøll, Samy Hadjadj, Peter Rossing, Edoardo Mannucci, Harald Darius, Chantal Mathieu
Publikováno v:
European Medical Journal Diabetes, Vol 1, Iss 1, Pp 22-29 (2013)
This meeting comprised two sessions: the morning session centred around glucagon-like peptide-1 receptor (GLP-1R) agonists and SGLT-2 inhibitors, a new class of glucose-lowering compounds, while the afternoon session focused on new results of cardiov
Externí odkaz:
https://doaj.org/article/d6559e1829db4644b219a1922fcb4dee
Autor:
Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley
Publikováno v:
JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawarene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1
https://pubmed.ncbi.nlm.nih.gov/34693236
https://pubmed.ncbi.nlm.nih.gov/34693236
Autor:
Manuel Romero-Gómez, Patrizia Carrieri, Mattias Ekstedt, Shira Zelber-Sagi, Katja Novak, Vlad Ratziu, Quentin M. Anstee, Frank Tacke, Adam Palayew, Jeffrey V. Lazarus, Helena Cortez-Pinto, Giulio Marchesini
Publikováno v:
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100234. ⟨10.1016/j.jhepr.2021.100234⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100234-(2021)
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100234. ⟨10.1016/j.jhepr.2021.100234⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100234-(2021)
[Background & Aims] Non-alcoholic fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly prevalent emerging condition that can be optimally managed through a multidisciplinary patient-cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237265ca3a905978c88b2731dd069191
https://hal.sorbonne-universite.fr/hal-03174867
https://hal.sorbonne-universite.fr/hal-03174867
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. J. Östgren, Victoria Delgado, Massimo Federici, T. В. Hansen, M. Lettino, V. Aboyans, Diederick E. Grobbee, D. C. Wheeler, А. Ceriello, Miguel Sousa-Uva, Gerasimos Filippatos, G. J. Bailey, Heikki V. Huikuri, Paul Valensi, Linda Mellbin, Peter Jüni, I. Johansson, M. Roffi, Nikolaus Marx, B. Rocca, Petar M. Seferovic, Peter J. Grant, Francesco Cosentino, N. Sattar
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 4 (2020)
The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::299f4d5ed8a7c244db37fb801f01a8e2
https://doi.org/10.15829/1560-4071-2020-3839
https://doi.org/10.15829/1560-4071-2020-3839
Autor:
Muhammad Ibrahim, Maryam Abimbola Mikail, Idris Adewale Ahmed, Rozana Othman, Mohammad Rais Mustafa
Publikováno v:
Saudi Journal of Biological Sciences, Vol 26, Iss 7, Pp 1519-1524 (2019)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
Non-alcoholic fatty liver disease (NAFLD) is a multi-factorial disease and the most common of chronic liver diseases worldwide. The four clinical-pathological entities which are usually followed by NAFLD course include non-alcoholic steatosis, non-al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f2047a39f739379090519c0d5b90777
https://pubmed.ncbi.nlm.nih.gov/31762620
https://pubmed.ncbi.nlm.nih.gov/31762620
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.